Targeting the Hedgehog Pathway in Cancer

Total Page:16

File Type:pdf, Size:1020Kb

Targeting the Hedgehog Pathway in Cancer REVIEWS Targeting the Hedgehog pathway in cancer Lee L. Rubin* and Frederic J. de Sauvage‡ Abstract | Several key signalling pathways, such as Hedgehog, Notch, Wnt and BMP–TGFβ– Activin (bone morphogenetic protein–transforming growth factor-β–Activin), are involved in most processes essential to the proper development of an embryo. It is also becoming increasingly clear that these pathways can have a crucial role in tumorigenesis when reactivated in adult tissues through sporadic mutations or other mechanisms. We will focus here on the Hedgehog pathway, which is abnormally activated in most basal cell carcinomas, and discuss potential therapeutic opportunities offered by the progress made in understanding this signalling pathway. Holoprosencephaly During embryonic development, the Hedgehog (Hh) Mechanisms of Hedgehog signal transduction A birth defect that can result as signalling pathway regulates proliferation and differen- ‘Hedgehog’ proteins (Hh) are secreted signalling pro- a consequence of insufficient tiation in a time- and position-dependent fashion (for a teins (FIG. 1) that were first discovered in Drosophila, Hh signalling. It relates to a review see REF. 1) so that developing tissues reach their along with many components of their signal transduc- failure of the brain to properly correct size with the appropriate cell types and adequate tion machinery5. They are highly hydrophobic proteins, separate into two halves and in its extreme form can be degrees of vascularization and innervation. The crucial which, after secretion, can diffuse and establish gradients associated with cyclopia, the developmental function of Hh signalling is illustrated by in tissues, which have a paramount role in the proper presence of a single centrally the dramatic consequences in human foetuses of defects development of the embryo1. In the context of embry- located eye. in the signalling pathways, such as holoprosencephaly in onic development, the cells that synthesize Hh ligands Sonic Hedgehog (SHH) mutants2. are distinct from the responsive cells, which are some- It is not difficult to imagine how a pathway that times juxtaposed to the producing cells, but can be at a regulates both proliferation and differentiation, when significant distance. mutated or otherwise deregulated, could contribute Although some crucial differences exist, the signal- to the onset of tumorigenesis or accelerate the rate of ling mechanisms are generally well conserved between tumour growth. Several other key signalling pathways Drosophila and higher organisms. Three Hh homologues that have crucial roles during embryonic development with different spatial and temporal distribution patterns have been found to play a role in tumorigenesis; for have been identified in humans: Sonic hedgehog (SHH), example, Notch1 mutations are found in most T-cell Indian hedgehog (IHH) and Desert hedgehog (DHH). acute lymphoblastic leukaemias (T-ALL)3, and the Wnt The Hh signalling cascade is initiated by Hh binding pathway is activated in the great majority of colon ade- to the Patched 1 protein (PTCH1 in humans, Ptch1 nocarcinoma cases, often through APC (adenomatous in mouse and Ptc in Drosophila) on the target cell (for polyposis coli) gene mutations4. a review see REF. 6). In the absence of the Hh ligand, *Harvard Stem Cell Institute, The Hh pathway has a well-recognized involvement PTCH1 represses the activity of Smoothened (SMOH Biolabs, Room 150, in two types of cancer with an unmet need for drug in humans and Smo in mouse/Drosophila), a G-protein- 16 Divinity Avenue, development: basal cell carcinoma, the most common coupled receptor (GPCR)-like receptor, presumably by Cambridge, Massachusetts cancer in the Western world, and medulloblastoma, a preventing its localization to the cell surface7 (FIG. 1). 02138, USA. ‡Department of Molecular childhood cancer with an invariably poor prognosis. Binding of Hh ligand to PTCH1 causes inhibition of Biology, Genentech, Inc., This review provides a brief overview of Hh signalling, SMOH to be relieved and the Hh signal is transmitted via South San Francisco, discusses the recent advances in the design of small- a protein complex that includes, in Drosophila, pathway- California 94080, USA. molecule and antibody-based inhibitors targeting this specific components such as the atypical kinesin-like Correspondence to L.L.R.: e-mail: signalling cascade, and summarizes relatively new con- protein Costal 2 (Cos2), Fused (Fu), a serine-threonine [email protected] nections between the Hh pathway and a variety of other protein kinase, Suppressor of Fused (SuFu) and the doi:10.1038/nrd2086 solid tumours. zinc-finger transcription factor cubitus interruptus (Ci). 1026 | DECEMBER 2006 | VOLUME 5 www.nature.com/reviews/drugdisc © 2006 Nature Publishing Group REVIEWS Ci is regulated at several levels via phosphorylation a Cilium through kinases such as protein kinase A (PKA), glycogen synthase kinase 3β (GSK3β) and casein kinase 1α (CK1α), which have a crucial role in the processing, activity and nuclear localization of Ci. In the absence of Hh signalling, Ci is cleaved, and its amino-terminal frag- PKA ment acts as an inhibitor of Hh target gene transcription. CK1α Upon Hh signalling, the cleavage of Ci is prevented and PTCH1 GSK3β the full-length molecule becomes a labile activator of Hh target gene transcription8. SMOH However, the situation in higher organisms is not clear, because Cos2 and Fu, which are crucial for signal- ling in the fly, do not seem to be conserved in mammals. (FIG. 1) P In contrast, mammalian Hh signalling requires P Nucleus 9–11 Endogenous P βTrCP the presence of non-motile cilia to which SMOH and ligand? GLI1 GLI2 GLI3 GLIR other downstream pathway components need to transit in order to achieve activation of GLI transcription fac- 12 Hh target tors, the Ci orthologues . Furthermore, the activator and genes repressor forms of Ci seem to have evolved into three SUFU GLIA separate zinc-finger proteins, with GLI1 and GLI2 func- 13 Iguana tioning mostly as activators and GLI3 as a repressor . The mechanism by which this signalling cascade regulates proliferation is now relatively well under- b Endogenous SMOH ligand, Cilium stood and involves the activation of cyclins and cyclin- SMOH agonist dependent kinases14. The control of differentiation Synthetic might be more complex, occurring via the production antagonist of other secreted proteins, including neurotrophic and α SMOH 15 Soluble -Hh angiogenic factors . receptor monoclonal In general terms, it seems clear that the degree of Hh antibody signalling in the adult is much reduced compared with PTCH1 G protein? that in the embryo or neonate, at least in the mouse, and GLI1 GLI2 GLI3 has only conclusively been detected in a few sites such Hedgehog as CNS neural stem cells16–19 (which are responsive to Nucleus Hh activation and express detectable levels of Ptch and 20 Inhibitors A Gli), as well as in gut epithelium . This does not imply of Hh GLI processing that the Hh pathway is without essential function in the adult, however. In addition, evidence is increasing that Internalized Hh target genes some of the same processes and pathways that are so prominent during development are reactivated by tis- sue damage and stimulate tissue repair15,21,22, including (PTCH1, GLI1) peripheral nerve regeneration23. However, in the past few years it has become clear that aberrant activation of the Figure 1 | A schematic of the vertebrate Hh signalling pathway in the absence or Hh signalling pathway can lead to cancer. presence of Hh ligands. The model illustrated here is based on current understanding of the Hedgehog (Hh) pathway in vertebrates. In the unliganded state (no Hh; a), Patched 1 Hh pathway mutations and cancer (PTCH1), a 12-transmembrane (12-TM) domain protein, is located, at least in part, on the The first connection between aberrant Hh signalling and plasma membrane, and the 7-TM protein GPCR-like receptor Smoothened (SMOH) is predominantly located in the membrane of intracellular endosomes. It is proposed that an cancer was the discovery that the rare condition Gorlin 24,25 endogenous intracellular small molecule that acts as an agonist for SMOH (as is often true syndrome is caused by a mutation in PTCH1 . Gorlin for GPCRs) is transported outside the cell by PTCH1 so that it is not able to bind to SMOH. patients develop numerous basal cell carcinomas (BCCs) Under these circumstances, different kinases phosphorylate GLI2/3, creating a repressor during their lifetimes and are predisposed to other kinds form of this transcription factor (GLIR). Iguana and SUFU prevent the active form of GLI (GLIA) of cancer as well, especially medulloblastoma, a tumour from transactivating Hh-responsive genes in a manner that is still not completely of cerebellar granule neuron progenitor cells, and rhab- understood. Upon binding an Hh ligand (b)72–74, PTCH1 is internalized, and apparently domyosarcoma, a muscle tumour. More importantly, destabilized, so that it can no longer transport the endogenous agonist molecules outwards. it was further determined that a large majority of spo- This allows them to accumulate intracellularly and activate SMOH, which itself translocates radically occurring BCCs also involve hyper-activated to the plasma membrane, apparently concentrating in cilia in at least some types of cells. Hh signalling, as judged by high levels of mRNA of the SMOH then engages as-yet-undefined components of the signalling machinery, 26,27 culminating in the appearance of activator forms of GLI that then regulate the expression of Hh target genes GLI1 and PTCH1 in tumour cells . Hh target genes. The known synthetic small-molecule SMOH agonists and antagonists bind Inactivating mutations in PTCH1 occur most commonly to the same site as the putative endogenous ligand. Modified, with permission, from REF. 75 in these tumours, with activating mutations in SMOH © (2006) The Company of Biologists. CK1α, casein kinase 1α; GPCR, G-protein-coupled found in about 10% of all BCCs28,29. In addition, one- receptor; GSK3β, glycogen synthase kinase 3β; PKA, protein kinase A.
Recommended publications
  • Functional Analysis of the Homeobox Gene Tur-2 During Mouse Embryogenesis
    Functional Analysis of The Homeobox Gene Tur-2 During Mouse Embryogenesis Shao Jun Tang A thesis submitted in conformity with the requirements for the Degree of Doctor of Philosophy Graduate Department of Molecular and Medical Genetics University of Toronto March, 1998 Copyright by Shao Jun Tang (1998) National Library Bibriothèque nationale du Canada Acquisitions and Acquisitions et Bibiiographic Services seMces bibliographiques 395 Wellington Street 395, rue Weifington OtbawaON K1AW OttawaON KYAON4 Canada Canada The author has granted a non- L'auteur a accordé une licence non exclusive licence alIowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distri%uteor sell reproduire, prêter' distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfiche/nlm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. Functional Analysis of The Homeobox Gene TLr-2 During Mouse Embryogenesis Doctor of Philosophy (1998) Shao Jun Tang Graduate Department of Moiecular and Medicd Genetics University of Toronto Abstract This thesis describes the clonhg of the TLx-2 homeobox gene, the determination of its developmental expression, the characterization of its fiuiction in mouse mesodem and penpheral nervous system (PNS) developrnent, the regulation of nx-2 expression in the early mouse embryo by BMP signalling, and the modulation of the function of nX-2 protein by the 14-3-3 signalling protein during neural development.
    [Show full text]
  • Visualizing Morphogenesis with the Processing Programming Language 15
    Visualizing Morphogenesis with the Processing Programming Language 15 Visualizing Morphogenesis with the Processing Programming Language Avik Patel, Amar Bains, Richard Millet, and Tamira Elul changing tissue shapes. A powerful technique for elucidating the We used Processing, a visual artists’ programming dynamic cellular mechanisms of morphogenesis is time-lapse video- language developed at MIT Media Lab, to simulate microscopic imaging of cells in embryonic tissues undergoing cellular mechanisms of morphogenesis – the generation morphogenesis (Elul and Keller 2000; Elul et al., 1997; Harris et al., of form and shape in embryonic tissues. Based on 1987). The mechanisms underlying morphogenetic processes can be clarified by observation of cell dynamics from these time-lapse video observations of in vivo time-lapse image sequences, we sequences. Morphometric measurement further defines the created animations of neural cell motility responsible for quantitative and statistical relationships between the cell dynamics that elongating the spinal cord, and of optic axon branching underlie morphogenesis (Kim and Davidson 2011; Marshak et al., dynamics that establish primary visual connectivity. 2007; Elul et al., 1997; Witte et al., 1996). Mathematical These visual models underscore the significance of the decomposition of cell dynamics additionally facilitates the computational decomposition of cellular dynamics computational modeling of cellular mechanisms that drive underlying morphogenesis. morphogenesis (Satulovsky et al., 2008). Methods In this paper, we use the Processing programming language to visualize dynamic cell behaviors driving morphogenesis in the Introduction developing nervous system. Based on in vivo time-lapse image sequences, we created models of cell dynamics underlying two Processing is a Java based software language and environment morphogenetic processes in the developing nervous system.
    [Show full text]
  • Transformations of Lamarckism Vienna Series in Theoretical Biology Gerd B
    Transformations of Lamarckism Vienna Series in Theoretical Biology Gerd B. M ü ller, G ü nter P. Wagner, and Werner Callebaut, editors The Evolution of Cognition , edited by Cecilia Heyes and Ludwig Huber, 2000 Origination of Organismal Form: Beyond the Gene in Development and Evolutionary Biology , edited by Gerd B. M ü ller and Stuart A. Newman, 2003 Environment, Development, and Evolution: Toward a Synthesis , edited by Brian K. Hall, Roy D. Pearson, and Gerd B. M ü ller, 2004 Evolution of Communication Systems: A Comparative Approach , edited by D. Kimbrough Oller and Ulrike Griebel, 2004 Modularity: Understanding the Development and Evolution of Natural Complex Systems , edited by Werner Callebaut and Diego Rasskin-Gutman, 2005 Compositional Evolution: The Impact of Sex, Symbiosis, and Modularity on the Gradualist Framework of Evolution , by Richard A. Watson, 2006 Biological Emergences: Evolution by Natural Experiment , by Robert G. B. Reid, 2007 Modeling Biology: Structure, Behaviors, Evolution , edited by Manfred D. Laubichler and Gerd B. M ü ller, 2007 Evolution of Communicative Flexibility: Complexity, Creativity, and Adaptability in Human and Animal Communication , edited by Kimbrough D. Oller and Ulrike Griebel, 2008 Functions in Biological and Artifi cial Worlds: Comparative Philosophical Perspectives , edited by Ulrich Krohs and Peter Kroes, 2009 Cognitive Biology: Evolutionary and Developmental Perspectives on Mind, Brain, and Behavior , edited by Luca Tommasi, Mary A. Peterson, and Lynn Nadel, 2009 Innovation in Cultural Systems: Contributions from Evolutionary Anthropology , edited by Michael J. O ’ Brien and Stephen J. Shennan, 2010 The Major Transitions in Evolution Revisited , edited by Brett Calcott and Kim Sterelny, 2011 Transformations of Lamarckism: From Subtle Fluids to Molecular Biology , edited by Snait B.
    [Show full text]
  • The Transcriptional Activator PAX3–FKHR
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press The transcriptional activator PAX3–FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo Frédéric Relaix,1 Mariarosa Polimeni,2 Didier Rocancourt,1 Carola Ponzetto,3 Beat W. Schäfer,4 and Margaret Buckingham1,5 1CNRS URA 2375, Department of Developmental Biology, Pasteur Institute, 75724 Paris Cedex 15, France; 2Department of Experimental Medicine, Section of Anatomy, University of Pavia, 27100 Pavia, Italy; 3Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, 10126 Turin, Italy; 4Division of Clinical Chemistry and Biochemistry, Department of Pediatrics, University of Zurich, CH-8032 Zurich, Switzerland Pax3 is a key transcription factor implicated in development and human disease. To dissect the role of Pax3 in myogenesis and establish whether it is a repressor or activator, we generated loss- and gain-of-function alleles by targeting an nLacZ reporter and a sequence encoding the oncogenic fusion protein PAX3–FKHR into the Pax3 locus. Rescue of the Pax3 mutant phenotypes by PAX3–FKHR suggests that Pax3 acts as a transcriptional activator during embryogenesis. This is confirmed by a Pax reporter mouse. However, mice expressing PAX3–FKHR display developmental defects, including ectopic delamination and inappropriate migration of muscle precursor cells. These events result from overexpression of c-met, leading to constitutive activation of Met signaling, despite the absence of the ligand SF/HGF. Haploinsufficiency of c-met rescues this phenotype, confirming the direct genetic link with Pax3. The gain-of-function phenotype is also characterized by overactivation of MyoD.
    [Show full text]
  • Nicotinic Receptor Alpha7 Expression During Tooth Morphogenesis Reveals Functional Pleiotropy
    Nicotinic Receptor Alpha7 Expression during Tooth Morphogenesis Reveals Functional Pleiotropy Scott W. Rogers1,2*, Lorise C. Gahring1,3 1 Geriatric Research, Education and Clinical Center, Veteran’s Administration, Salt Lake City, Utah, United States of America, 2 Department of Neurobiology and Anatomy, University of Utah School of Medicine, Salt Lake City, Utah, United States of America, 3 Division of Geriatrics, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, United States of America Abstract The expression of nicotinic acetylcholine receptor (nAChR) subtype, alpha7, was investigated in the developing teeth of mice that were modified through homologous recombination to express a bi-cistronic IRES-driven tau-enhanced green fluorescent protein (GFP); alpha7GFP) or IRES-Cre (alpha7Cre). The expression of alpha7GFP was detected first in cells of the condensing mesenchyme at embryonic (E) day E13.5 where it intensifies through E14.5. This expression ends abruptly at E15.5, but was again observed in ameloblasts of incisors at E16.5 or molar ameloblasts by E17.5–E18.5. This expression remains detectable until molar enamel deposition is completed or throughout life as in the constantly erupting mouse incisors. The expression of alpha7GFP also identifies all stages of innervation of the tooth organ. Ablation of the alpha7-cell lineage using a conditional alpha7Cre6ROSA26-LoxP(diphtheria toxin A) strategy substantially reduced the mesenchyme and this corresponded with excessive epithelium overgrowth consistent with an instructive role by these cells during ectoderm patterning. However, alpha7knock-out (KO) mice exhibited normal tooth size and shape indicating that under normal conditions alpha7 expression is dispensable to this process.
    [Show full text]
  • Genomic Targeting of Epigenetic Probes Using a Chemically Tailored Cas9 System
    Genomic targeting of epigenetic probes using a chemically tailored Cas9 system Glen P. Liszczaka, Zachary Z. Browna, Samuel H. Kima, Rob C. Oslunda, Yael Davida, and Tom W. Muira,1 aDepartment of Chemistry, Princeton University, Princeton, NJ 08544 Edited by James A. Wells, University of California, San Francisco, CA, and approved December 13, 2016 (received for review September 20, 2016) Recent advances in the field of programmable DNA-binding proteins Here, we report a method that combines the versatility of have led to the development of facile methods for genomic pharmacologic manipulation with the specificity of a genetically localization of genetically encodable entities. Despite the extensive programmable DNA-binding protein. Our strategy uses a utility of these tools, locus-specific delivery of synthetic molecules chemically tailored dCas9 to display a pharmacologic agent at a remains limited by a lack of adequate technologies. Here we combine genetic locus of interest in live mammalian cells (Fig. 1). This is trans the flexibility of chemical synthesis with the specificity of a pro- accomplished using split intein-mediated protein -splicing grammable DNA-binding protein by using protein trans-splicing to (PTS) to site-specifically link a recombinant dCas9:guide RNA ligate synthetic elements to a nuclease-deficient Cas9 (dCas9) (gRNA) complex to the synthetic cargo of choice (22). Indeed, in vitro and subsequently deliver the dCas9 cargo to live cells. we show that the remarkable specificity, efficiency, and speed of PTS allow the direct generation of desired dCas9 conjugates The versatility of this technology is demonstrated by delivering within the cell culture media, thereby facilitating a streamlined dCas9 fusions that include either the small-molecule bromodomain “one-pot” approach for genomic targeting of the reaction product.
    [Show full text]
  • Delta-Notch Signaling: the Long and the Short of a Neuron’S Influence on Progenitor Fates
    Journal of Developmental Biology Review Delta-Notch Signaling: The Long and the Short of a Neuron’s Influence on Progenitor Fates Rachel Moore 1,* and Paula Alexandre 2,* 1 Centre for Developmental Neurobiology, King’s College London, London SE1 1UL, UK 2 Developmental Biology and Cancer, University College London Great Ormond Street Institute of Child Health, London WC1N 1EH, UK * Correspondence: [email protected] (R.M.); [email protected] (P.A.) Received: 18 February 2020; Accepted: 24 March 2020; Published: 26 March 2020 Abstract: Maintenance of the neural progenitor pool during embryonic development is essential to promote growth of the central nervous system (CNS). The CNS is initially formed by tightly compacted proliferative neuroepithelial cells that later acquire radial glial characteristics and continue to divide at the ventricular (apical) and pial (basal) surface of the neuroepithelium to generate neurons. While neural progenitors such as neuroepithelial cells and apical radial glia form strong connections with their neighbours at the apical and basal surfaces of the neuroepithelium, neurons usually form the mantle layer at the basal surface. This review will discuss the existing evidence that supports a role for neurons, from early stages of differentiation, in promoting progenitor cell fates in the vertebrates CNS, maintaining tissue homeostasis and regulating spatiotemporal patterning of neuronal differentiation through Delta-Notch signalling. Keywords: neuron; neurogenesis; neuronal apical detachment; asymmetric division; notch; delta; long and short range lateral inhibition 1. Introduction During the development of the central nervous system (CNS), neurons derive from neural progenitors and the Delta-Notch signaling pathway plays a major role in these cell fate decisions [1–4].
    [Show full text]
  • Geometry, Epistasis, and Developmental Patterning
    Geometry, epistasis, and developmental patterning Francis Corson and Eric Dean Siggia1 Center for Studies in Physics and Biology, The Rockefeller University, New York, NY 10021 This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2009. Contributed by Eric Dean Siggia, February 6, 2012 (sent for review November 28, 2011) Developmental signaling networks are composed of dozens of (5) shows that even differentiation can be reversed. Yet they have components whose interactions are very difficult to quantify in provided a useful guide to experiments. an embryo. Geometric reasoning enumerates a discrete hierarchy These concepts admit a natural geometric representation, of phenotypic models with a few composite variables whose para- which can be formalized in the language of dynamical systems, meters may be defined by in vivo data. Vulval development in also called the geometric theory of differential equations (Fig. 1). ’ the nematode Caenorhabditis elegans is a classic model for the in- When the molecular details are not accessible, a system s effec- tegration of two signaling pathways; induction by EGF and lateral tive behavior may be represented in terms of a small number of signaling through Notch. Existing data for the relative probabilities aggregate variables, and qualitatively different behaviors enum- of the three possible terminal cell types in diverse genetic back- erated according to the geometrical structure of trajectories or grounds as well as timed ablation of the inductive signal favor topology. The fates that are accessible to a cell are associated with attractors—the valleys in Waddington’s “epigenetic landscape” one geometric model and suffice to fit most of its parameters.
    [Show full text]
  • Development and Evolution
    AccessScience from McGraw-Hill Education Page 1 of 4 www.accessscience.com Development and evolution Contributed by: Brian K. Hall Publication year: 2010 The disciplines of developmental biology (or embryology) and evolutionary biology have come together twice—once as evolutionary embryology in the late nineteenth century and again as evolutionary developmental biology (evo-devo, as it is typically known) in the late twentieth century. The current intersections of development and evolution are proving to be of paramount importance for creating a fully integrated theory of biology. History Prior to and into the nineteenth century, the word “evolution” had a completely different meaning from its usage today. Then, it was used to describe a particular type of embryonic or larval development—the preformation and unfolding of a more or less fully formed organism from an embryonic or larval stage (for example, a butterfly from a caterpillar, or aphids from the body of an adult female). In fact, Charles Darwin did not use the word “evolution” per se in On the Origin of Species , which was published in 1859, although “evolved” was the final word of his book. To reach its present-day definition, the term “evolution” had to undergo a slow transformation from development within a single generation to transformation (transmutation) between generations. As for the field of developmental biology, in the nineteenth century, embryology (referring to the study of embryonic development) was a progressive field in biology, with researchers describing normal development and then manipulating animal embryos [ experimental or physiological embryology (also known as developmental mechanics)] in search of altered outcomes that would help explain how development occurred.
    [Show full text]
  • Synthetic Morphogenesis
    Downloaded from http://cshperspectives.cshlp.org/ on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Synthetic Morphogenesis Brian P. Teague, Patrick Guye, and Ron Weiss Synthetic Biology Center, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Correspondence: [email protected] Throughout biology, function is intimately linked with form. Across scales ranging from subcellular to multiorganismal, the identity and organization of a biological structure’s subunits dictate its properties. The field of molecular morphogenesis has traditionally been concerned with describing these links, decoding the molecular mechanisms that give rise to the shape and structure of cells, tissues, organs, and organisms. Recent advances in synthetic biology promise unprecedented control over these molecular mechanisms; this opens the path to not just probing morphogenesis but directing it. This review explores several frontiers in the nascent field of synthetic morphogenesis, including programmable tissues and organs, synthetic biomaterials and programmable matter, and engineering complex morphogenic systems de novo. We will discuss each frontier’s objectives, current approaches, constraints and challenges, and future potential. hat is the underlying basis of biological 2014). As the mechanistic underpinnings of Wstructure? Speculations were based on these processes are elucidated, opportunities macroscopic observation until the 17th century, arise to use this knowledge to direct mor- when Antonie van Leeuwenhoek and Robert phogenesis toward novel, useful ends. We call Hooke discovered that organisms were com- this emerging field of endeavor “synthetic mor- posed of microscopic cells (Harris 1999), and phogenesis.” Inspired by and based on natural that the size and shape of the cells affected the morphogenic systems, synthetic morphogenesis properties of the structures they formed.
    [Show full text]
  • Principles of Differentiation and Morphogenesis
    Swarthmore College Works Biology Faculty Works Biology 2016 Principles Of Differentiation And Morphogenesis Scott F. Gilbert Swarthmore College, [email protected] R. Rice Follow this and additional works at: https://works.swarthmore.edu/fac-biology Part of the Biology Commons Let us know how access to these works benefits ouy Recommended Citation Scott F. Gilbert and R. Rice. (2016). 3rd. "Principles Of Differentiation And Morphogenesis". Epstein's Inborn Errors Of Development: The Molecular Basis Of Clinical Disorders On Morphogenesis. 9-21. https://works.swarthmore.edu/fac-biology/436 This work is brought to you for free by Swarthmore College Libraries' Works. It has been accepted for inclusion in Biology Faculty Works by an authorized administrator of Works. For more information, please contact [email protected]. 2 Principles of Differentiation and Morphogenesis SCOTT F. GILBERT AND RITVA RICE evelopmental biology is the science connecting genetics with transcription factors, such as TFHA and TFIIH, help stabilize the poly­ anatomy, making sense out of both. The body builds itself from merase once it is there (Kostrewa et al. 2009). Dthe instructions of the inherited DNA and the cytoplasmic system that Where and when a gene is expressed depends on another regula­ interprets the DNA into genes and creates intracellular and cellular tory unit of the gene, the enhancer. An enhancer is a DNA sequence networks to generate the observable phenotype. Even ecological fac­ that can activate or repress the utilization of a promoter, controlling tors such as diet and stress may modify the DNA such that different the efficiency and rate of transcription from that particular promoter.
    [Show full text]
  • Genetic Dissection of Developmental Pathways*§ †
    Genetic dissection of developmental pathways*§ † Linda S. Huang , Department of Biology, University of Massachusetts-Boston, Boston, MA 02125 USA Paul W. Sternberg, Howard Hughes Medical Institute and Division of Biology, California Institute of Technology, Pasadena, CA 91125 USA Table of Contents 1. Introduction ............................................................................................................................1 2. Epistasis analysis ..................................................................................................................... 2 3. Epistasis analysis of switch regulation pathways ............................................................................ 3 3.1. Double mutant construction ............................................................................................. 3 3.2. Interpretation of epistasis ................................................................................................ 5 3.3. The importance of using null alleles .................................................................................. 6 3.4. Use of dominant mutations .............................................................................................. 7 3.5. Complex pathways ........................................................................................................ 7 3.6. Genetic redundancy ....................................................................................................... 9 3.7. Limits of epistasis ......................................................................................................
    [Show full text]